Drug Retail

First Global is out with its report today on Walgreens (NYSE: WAG), reiterating Market Perform. In a note to clients, First Global writes, "WAG has decided not to renew its contract with pharmacy benefit manager, Express Scripts Inc. (NASDAQ: ESRX), with effect from January 1, 2012, due to...

Goldman Sachs has raised the price target on Rite Aid (NYSE: RAD) from $1.25 to $1.40 and maintains its Neutral rating.

Jefferies is out with its report today on Express Scripts (NASDAQ: ESRX), reiterating Buy. In a note to clients, Jefferies writes, "WAG (NYSE: WAG)/ESRX contract negotiations may be stalled for the moment but are far from dead. Potential earnings loss at WAG from a terminated ESRX relationship...

Shares of Rite Aid Corp (NYSE: RAD) gained about 3.5% after the company reported narrower-than-expected first-quarter loss. Rite Aid's quarterly narrowed to $65.5 million, or $0.07 per share, from $76 million, or $0.09 per share, in the year-earlier period. Its revenue came in at $6.39 billion....

Rite Aid Corporation (NYSE: RAD) today reported financial results for the first quarter ended May 28, 2011. The company reported revenues of $6.4 billion, a net loss of $63.1 million or $0.07 per diluted share and Adjusted EBITDA of $262.9 million or 4.1 percent of revenues. Results benefited from...

Rite Aid Corp (NYSE: RAD) reported narrower-than-expected first-quarter loss on Thursday. Rite Aid's quarterly narrowed to $65.5 million, or $0.07 per share, from $76 million, or $0.09 per share, in the year-earlier period. Its revenue came in at $6.39 billion. However, analysts were expecting a...

Rite Aid Corporation (NYSE: RAD) today reported financial results for the first quarter ended May 28, 2011. The company reported revenues of $6.4 billion, a net loss of $63.1 million or $0.07 per diluted share and Adjusted EBITDA of $262.9 million or 4.1 percent of revenues. Results benefited...

Discover Financial Services (NYSE: DFS) is projected to post its Q2 EPS at $0.70 on revenue of $1.70 billion. H&R Block Inc (NYSE: HRB) is expected to report its Q4 earnings at $2.15 per share on revenue of $2.32 billion. Oracle Corp (NASDAQ: ORCL) is estimated to post its Q4 earnings at $0...

According to Goldman Sachs, Walgreen (NYSE: WAG) price target is decreased to $47. Goldman Sachs said that WAG's underlying May quarter results exceeded our expectation, with EBIT beating our forecast in high-quality fashion, as gross margin rate exceeded our estimate despite input cost pressures...

According to Citi, Walgreen (NYSE: WAG) reported F3Q11 EPS of $0.65 per diluted share, above its estimate of $0.63, above consensus of $0.62, and vs. $0.52 last year (excld. one-time items LY). Citi said that reported F3Q11 EPS included a (-$0.01)/share impact from restructuring and restructuring-...

Morgan Stanley reiterated its Neutral rating on Walgreen Company (NYSE: WAG). At the same time, Morgan Stanley left its price target unchanged at $43 after the company reported better than expected quarterly earnings results. In a research report published today, Morgan Stanley states, "WAG...

Jefferies reiterated its Buy rating on Walgreen (NYSE: WAG). At the same time, Jefferies left its price target on the company's stock unchanged at $50 after the company's reported better than expected quarterly earnings. In a research report published today, Jefferies states, "Walgreens reported...

Goldman Sachs has lowered the price target on Walgreen Company (NYSE: WAG) from $48 to $47 and maintains its Buy rating.

Express Scripts, Inc. (NASDAQ: ESRX) said today it is open to continued negotiations with Walgreens (NYSE: WAG) to make prescription drugs affordable and accessible for American families. "In these challenging economic times, it is critical that we all work together to keep medicines affordable...

Walgreen Company (NYSE: WAG) shares are down more than 4% today, after the company reported quarterly earnings this morning, and said that its deal with Express Scripts (NASDAQ: ESRX) would stop. Walgreen's reported third quarter earnings of 65 cents per share on $18.37 billion in revenues. Wall...